Subway comes up with $5 billion debt plan to clinch $10 billion-plus sale -sources

By Abigail Summerville and Anirban Sen NEW YORK (Reuters) -The bankers running the sale process for Subway have given the private equity firms vying for the sandwich chain a $5 billion acquisition financing plan, hoping to overcome a challenging environment for leveraged buyouts and fetch the company’s asking price of more than $10 billion, people…

Read More

Armenian, Azerbaijani ministers hold talks in US over Karabakh dispute

WASHINGTON (Reuters) -U.S. Secretary of State Antony Blinken met the foreign ministers of Armenia and Azerbaijan in Washington on Monday as part of efforts to ease friction between the South Caucasus rivals. Tensions have flared anew after Azerbaijan installed a road checkpoint at the start of the Lachin Corridor, the only route linking Armenia to…

Read More

Japan’s Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments

By Rocky Swift TOKYO (Reuters) -Japan’s Astellas Pharma said on Monday it agreed to buy U.S. drugmaker Iveric Bio Inc for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmology treatments. The deal marks the fifth major overseas acquisition by Astellas, Japan’s third biggest drugmaker by sales, since 2019…

Read More

US construction spending rebounds in March on nonresidential structures

WASHINGTON (Reuters) – U.S. construction spending increased more than expected in March, boosted by investment in nonresidential structures, but single-family homebuilding remained depressed amid higher mortgage rates. The Commerce Department said on Monday that construction spending rose 0.3% in March after declining 0.3% in February. Economists polled by Reuters had forecast construction spending gaining 0.1%….

Read More